Pollen count warning: Hay fever patients at risk today - how to treat symptoms

POLLEN COUNT UK forecast: Hay fever patients can expect some unwanted allergy symptoms today . If you do develop hay fever signs, including runny noses and sneezing, this is the best way to get rid of your symptoms.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

This article summarizes available data on the use of bilastine in the treatment of allergic disorders in different age groups, including younger and older adults, and school-age children and adolescents. Methods: A PubMed literature search ("bilastine") was conducted to 25 February 2019. Additional literature known to the authors and identified from the reference lists of cited publications was included. Results: Bilastine is administered orally at a dose of 20 mg once daily in adults and adolescents aged ≥12 years and 10 mg once daily in children aged 6 to
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
In this study we evaluated the effects of protein extracts of probiotics in the amelioration of AR.MethodsExtracts ofBifidobacterium infantis (EBI) were prepared by lysing the live probiotics. AR mice were developed to be used to evaluate the therapeutic efficacy of EBI.ResultsThe results show that EBI induced interleukin (IL) ‐10‒producing dendritic cells (DCs) via increasing IL‐35 and signal transducer and activator of transcription 3 (STAT3) phosphorylation. IL‐10‒expressing DCs induced IL‐10‒producing B cells (B10 cells), with the latter showing immunosuppressive functions. After challenge with specific a...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
This article summarizes the five main principles of personal data protection to be respected during the development of the app: purpose, proportionality and relevance, limited retention period, security and confidentiality, as well as the rights of the people who are involved in the management of the personal data (including withdrawal and modification). PMID: 31611024 [PubMed - as supplied by publisher]
Source: Revue des Maladies Respiratoires - Category: Respiratory Medicine Tags: Rev Mal Respir Source Type: research
The selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease and depends on many factors. Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines have considerably improved the treatment of allergic rhinitis. However, there is an increasing trend toward use of real-world evidence to inform clinical practice, especially because randomized controlled trials are often limited with regard to the applicability of results. The Contre les Maladies Chroniques pour un Vieillissement Actif (MACVIA) algorithm has proposed an allergic rhinitis treatment by a consensus group.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Tags: Review article Source Type: research
Conditions:   Allergy;   Respiratory Disease Intervention:   Drug: Allergy immunotherapy (AIT) Sponsor:   ALK-Abelló A/S Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractThe paper aims to leverage the highly unstructured user-generated content in the context of pollen allergy surveillance using neural networks with character embeddings and the attention mechanism. Currently, there is no accurate representation of hay fever prevalence, particularly in real-time scenarios. Social media serves as an alternative to extract knowledge about the condition, which is valuable for allergy sufferers, general practitioners, and policy makers. Despite tremendous potential offered, conventional natural language processing methods prove limited when exposed to the challenging nature of user-gener...
Source: Health Information Science and Systems - Category: Information Technology Source Type: research
The objective of the study was to compare the efficacy of the phototherapy device on the relief of a range of symptoms provoked by indoor and outdoor allergens. A phototherapy emits visible light (mUV/VIS) and infrared light, and was compared to a placebo device which did not emit light on two groups of allergic rhinitis sufferers. Rhinophototherapy improved nasal symptoms of allergic rhinitis arising from exposure to indoor and outdoor allergens. The difference in the intensity of symptoms scored at the baseline, and at the final visit for the group using the photoperiod device was significantly lower. The device could po...
Source: European Annals of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research
In conclusion this real-life study showed that during an ORL visit it is possible to suspect AR in children with turbinate hypertrophy, familial atopy, nasal pale mucosa, adenoid enlargement, and asthma comorbidity. PMID: 31594289 [PubMed - as supplied by publisher]
Source: European Annals of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research
ConclusionsSM are a  common sensitization in the study population and should be included in standard skin prick test arrays. Cross sensitization to house dust mites is limited and nasal symptoms are most frequent. Nasal provocation testing is necessary to secure clinical diagnosis of allergy and further research is ne eded to evaluate the clinical relevance of the high sensitization rates found for intradermal testing.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research
ConclusionsThis responder analysis confirms the superior efficacy of rupatadine vs placebo to treat SAR. Rupatadine promoted higher proportions of responders according to stringent response criteria and in a dose-dependent manner, with faster and higher response rates in the 20  mg group.
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Hay Fever | Health | Warnings